281 related articles for article (PubMed ID: 28188254)
1. Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor-Mediated Signaling in Human Amnion and Myometrium.
Kim SH; Pohl O; Chollet A; Gotteland JP; Fairhurst AD; Bennett PR; Terzidou V
Mol Pharmacol; 2017 Apr; 91(4):403-415. PubMed ID: 28188254
[TBL] [Abstract][Full Text] [Related]
2. The oxytocin receptor antagonist, Atosiban, activates pro-inflammatory pathways in human amnion via G(αi) signalling.
Kim SH; MacIntyre DA; Hanyaloglu AC; Blanks AM; Thornton S; Bennett PR; Terzidou V
Mol Cell Endocrinol; 2016 Jan; 420():11-23. PubMed ID: 26586210
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F
Kim SH; Riaposova L; Ahmed H; Pohl O; Chollet A; Gotteland JP; Hanyaloglu A; Bennett PR; Terzidou V
Sci Rep; 2019 Apr; 9(1):5792. PubMed ID: 30962532
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin activates NF-κB-mediated inflammatory pathways in human gestational tissues.
Kim SH; MacIntyre DA; Firmino Da Silva M; Blanks AM; Lee YS; Thornton S; Bennett PR; Terzidou V
Mol Cell Endocrinol; 2015 Mar; 403():64-77. PubMed ID: 25451977
[TBL] [Abstract][Full Text] [Related]
5. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats.
Engstrøm T; Bratholm P; Vilhardt H; Christensen NJ
Biol Reprod; 1999 Feb; 60(2):322-9. PubMed ID: 9915997
[TBL] [Abstract][Full Text] [Related]
6. A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes.
Lappas M
Mol Hum Reprod; 2017 Sep; 23(9):628-645. PubMed ID: 28911210
[TBL] [Abstract][Full Text] [Related]
7. The combination tocolytic effect of magnesium sulfate and an oxytocin receptor antagonist in myometrium from singleton and twin pregnancies.
Arrowsmith S; Neilson J; Wray S
Am J Obstet Gynecol; 2016 Dec; 215(6):789.e1-789.e9. PubMed ID: 27555315
[TBL] [Abstract][Full Text] [Related]
8. Effects of oxytocin receptor antagonist atosiban on pregnant myometrium in vitro.
Büscher U; Chen FC; Riesenkampff E; von Dehn D; David M; Dudenhausen JW
Obstet Gynecol; 2001 Jul; 98(1):117-21. PubMed ID: 11430968
[TBL] [Abstract][Full Text] [Related]
9. Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization.
Wrzal PK; Devost D; Pétrin D; Goupil E; Iorio-Morin C; Laporte SA; Zingg HH; Hébert TE
Cell Signal; 2012 Jan; 24(1):342-50. PubMed ID: 21963428
[TBL] [Abstract][Full Text] [Related]
10. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
Reinheimer TM
BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
[TBL] [Abstract][Full Text] [Related]
11. The Adaptor Protein p62 Mediates Nuclear Factor κB Activation in Response to Inflammation and Facilitates the Formation of Prolabor Mediators in Human Myometrium.
Lappas M
Reprod Sci; 2017 May; 24(5):762-772. PubMed ID: 27638291
[TBL] [Abstract][Full Text] [Related]
12. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban.
Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M
Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081
[TBL] [Abstract][Full Text] [Related]
13. Novel in vitro system for functional assessment of oxytocin action.
Devost D; Zingg HH
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E1-6. PubMed ID: 16954329
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of PKA-dependent and lipid-raft independent stimulation of Connexin43 expression by oxytoxin in mouse embryonic stem cells.
Yun SP; Park SS; Ryu JM; Park JH; Kim MO; Lee JH; Han HJ
Mol Endocrinol; 2012 Jul; 26(7):1144-57. PubMed ID: 22564436
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous contractions of myometrium from humans, non-human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro.
Wilson RJ; Allen MJ; Nandi M; Giles H; Thornton S
BJOG; 2001 Sep; 108(9):960-6. PubMed ID: 11563467
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women.
Pierzynski P; Lemancewicz A; Reinheimer T; Akerlund M; Laudanski T
J Soc Gynecol Investig; 2004 Sep; 11(6):384-7. PubMed ID: 15350251
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin receptor subtypes in the pregnant rat myometrium and decidua: pharmacological differentiations.
Chan WY; Chen DL; Manning M
Endocrinology; 1993 Mar; 132(3):1381-6. PubMed ID: 8382600
[TBL] [Abstract][Full Text] [Related]
18. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
[TBL] [Abstract][Full Text] [Related]
19. Functionally Selective Inhibition of the Oxytocin Receptor by Retosiban in Human Myometrial Smooth Muscle.
Brighton PJ; Fossler MJ; Quenby S; Blanks AM
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31907536
[TBL] [Abstract][Full Text] [Related]
20. Myometrial oxytocin receptor expression and intracellular pathways.
Yulia A; Johnson MR
Minerva Ginecol; 2014 Jun; 66(3):267-80. PubMed ID: 24971782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
